HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johnson, W. G. Search for Related Content PubMed PubMed Citation Articles by Johnson, W. G.

The clinical spectrum of hexosaminidase deficiency diseases

Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY

Address correspondence and reprint requests to Dr. Johnson, P & S 4-448, 630 West 168th Street, New York, NY 10032.

Hexosaminidase deficiency diseases or G_m2-gangliosidoses were originally described as infantile encephalopathies. Recently, hexosaminidase deficiencies have been found with different phenotypes, including juvenile and adult encephalopathies, cerebellar ataxias, and motor neuron diseases. Individual cases have resembled Ramsey-Hunt syndrome, olivopontocerebellar ataxia, Friedreich ataxia, amyotrophic lateral sclerosis, Kugelberg-Welander disease, Fazio-Londe disease, and Charcot-Marie-Tooth disease. Tremor, dystonia, spastic paresis, and psychosis have been seen. Since few diagnosable causes for these system atrophies are known, these patients should be tested for hexosaminidase deficiency. These recessive disorders fit a multiple loci/multiple alleles genetic scheme, and a clinical genetic classification is presented.

This article has been cited by other articles:

				G. M. MacQueen, P. I. Rosebush, and M. F. Mazurek Neuropsychiatric Aspects of the Adult Variant of Tay-Sachs Disease J Neuropsychiatry Clin Neurosci, February 1, 1998; 10(1): 10 - 19. [Abstract] [Full Text]

				B. A. Malow, A. C. Baker, and J. P. Blass Cultured Cells as a Screen for Novel Treatments of Alzheimer's Disease Arch Neurol, November 1, 1989; 46(11): 1201 - 1203. [Abstract] [PDF]

				S. H. Appel, V. Stockton-Appel, S. S. Stewart, and R. H. Kerman Amyotrophic Lateral Sclerosis: Associated Clinical Disorders and Immunological Evaluations Arch Neurol, March 1, 1986; 43(3): 234 - 238. [Abstract] [PDF]

				S. Parnes, G. Karpati, S. Carpenter, N. M. K. N. Y. Kin, L. S. Wolfe, and L. Suranyi Hexosaminidase-A Deficiency Presenting as Atypical Juvenile-onset Spinal Muscular Atrophy Arch Neurol, December 1, 1985; 42(12): 1176 - 1180. [Abstract] [PDF]